Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Can J Urol ; 20(2): 6707-13, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23587511

RESUMO

INTRODUCTION: Urinary prostate-specific antigen (uPSA) can be used as additional parameter of benign prostatic hyperplasia (BPH) progression. MATERIALS AND METHODS: From January 2001 to December 2011, uPSA was determined in 265 patients with benign prostate. Based on total prostate volume (TPV), the patients with benign prostate were divided in two groups: TPV < 31 mL and TPV ≥ 31 mL. Additional three groups were formed upon MTOPS study criteria: non- progressive BPH group (TPV < 31 mL, PSA < 1.6 ng/mL, age < 62 yrs), intermediate group (one, or two parameters {TPV, PSA, age} increased) and progressive BPH group (TPV ≥ 31 ml, PSA ≥ 1.6 ng/mL, age ≥ 62 yrs). RESULTS: Average uPSA values in the groups TPV < 31 mL and TPV ≥ 31 mL were 119.3 ± 124.5 and 255.5 ± 204.9 ng/mL, respectively and they were significantly different (p < 0.0001). Average uPSA values in the non- progressive BPH group, intermediate group and progressive BPH group were 86.8 ± 82.4 ng/mL, 166.6 ± 164.9 ng/mL and 274.9 ± 208.3 ng/mL, respectively and they were significantly different (p < 0.0001). The level of uPSA correlated significantly with TPV (r = 0.32, p < 0.0001). The cut off uPSA level of 150 ng/mL discriminates the patients with non-progressive BPH and progressive BPH with specificity of 0.83 and sensitivity of 0.67. CONCLUSION: The level of uPSA reflects prostatic hormonal activity and correlates with TPV, PSA and age. UPSA level ≥ 150 ng/mL can be used as additional predictive parameter of BPH progression.


Assuntos
Progressão da Doença , Antígeno Prostático Específico/urina , Hiperplasia Prostática/diagnóstico , Hiperplasia Prostática/urina , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/urina , Humanos , Masculino , Pessoa de Meia-Idade , Tamanho do Órgão , Valor Preditivo dos Testes , Próstata/patologia , Hiperplasia Prostática/patologia , Estudos Retrospectivos , Sensibilidade e Especificidade
2.
BJU Int ; 100(6): 1361-3, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17590179

RESUMO

OBJECTIVE: To analyse the indications, diagnosis, major causes and basic principles of surgical treatment of vesico-uterine fistulas (VUF). PATIENTS AND METHODS: From 1970 to 2006, 14 patients underwent surgical repair of VUF in two Belgrade hospitals. The most common cause of a fistula was previous Caesarean section (13/14). The mean (range) age was 27 (22-38) years. Five women underwent transvesical fistula suture, and nine underwent a transperitoneal surgical approach with the interposition of a tissue flap; an omental flap in five and a peritoneal flap in four. RESULTS: The mean (range) duration of surgery was 85 (70-120) min. The mean hospital stay was 14 (12-22) days. The urethral catheter was removed 10 days after surgery. One woman with no tissue flap repair relapsed and none of the women with a tissue flap repair relapsed. After surgery, eight patients became pregnant and underwent Caesarean section. CONCLUSION: Successful closure of VUF requires accurate diagnostic evaluation, appropriate repair using techniques that utilize basic surgical principles, and the careful application of interposing tissue flaps.


Assuntos
Fístula/cirurgia , Retalhos Cirúrgicos , Fístula da Bexiga Urinária/cirurgia , Doenças Uterinas/cirurgia , Adulto , Cesárea/efeitos adversos , Feminino , Fístula/diagnóstico por imagem , Fístula/etiologia , Humanos , Tempo de Internação , Radiografia , Estudos Retrospectivos , Resultado do Tratamento , Fístula da Bexiga Urinária/diagnóstico por imagem , Fístula da Bexiga Urinária/etiologia , Cateterismo Urinário , Procedimentos Cirúrgicos Urológicos , Doenças Uterinas/diagnóstico por imagem , Doenças Uterinas/etiologia
3.
BJU Int ; 97(3): 587-91, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16469032

RESUMO

OBJECTIVE: To evaluate the safety and efficacy of a modified technique for a sigma-rectum pouch (Mainz pouch II). PATIENTS AND METHODS: Between October 1994 and March 2003, a modified Mainz pouch II was constructed in 220 patients (153 men and 67 women, mean age 56.7 years) in a multicentre prospective study. The median follow-up (177 patients, 81%) was 21 (1-84) months. RESULTS: There were no peri-operative deaths; there were early complications in 24 patients, including prolonged ileus in six, pyelonephritis in 17, unilateral ureterohydronephrosis in 11, bilateral ureterohydronephrosis in two, and incipient renal failure in five. Late complications included ureteric implantation-site stenosis (unilateral in eight patients and bilateral in three). In all, 92 patients (52%) needed oral alkalizing medications and potassium supplementation because of hyperchloraemic metabolic acidosis. All but three patients (99%) were continent by day and at night. The mean (sd) voiding frequency was 4.2 (1.6) voids by day and 2.1 (0.5) at night. CONCLUSION: The Mainz pouch II is a simple and reproducible surgical technique, with good results in terms of mortality, morbidity, continence and overall quality of life. The main limitation is malignant transformation of the uretero-intestinal anastomosis. For selected cases, the technique is a good alternative to other types of continent urinary diversion.


Assuntos
Colo Sigmoide/cirurgia , Reto/cirurgia , Neoplasias da Bexiga Urinária/cirurgia , Coletores de Urina , Adulto , Idoso , Anastomose Cirúrgica/métodos , Cistectomia/métodos , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/etiologia , Estudos Prospectivos , Qualidade de Vida , Inquéritos e Questionários , Estreitamento Uretral/cirurgia , Procedimentos Cirúrgicos Urológicos/métodos , Fístula Vesicovaginal/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA